Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 1/20 | 0.58 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.54 |
| ▸ | MPO | P05164 | 5/20 | 0.53 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.53 |
| ▸ | HSPA5 | P11021 | 1/20 | 0.50 |
| ▸ | CA12 | O43570 | 4/20 | 0.47 |
| ▸ | CA2 | P00918 | 4/20 | 0.47 |
| ▸ | CA9 | Q16790 | 4/20 | 0.47 |
| ▸ | BID | P55957 | 1/20 | 0.46 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.46 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.46 |
| ▸ | BAK1 | Q16611 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 2/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.45 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.45 |
| ▸ | HTR1A | P08908 | 1/20 | 0.44 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10522207 | 1.00 | MGLL (0.58) | MGLLTAAR1MPOSLC6A4HSPA5 | |
| SCHEMBL8517640 | 1.00 | MGLL (0.58) | MGLLTAAR1MPOSLC6A4HSPA5 | |
| SCHEMBL13446845 | 1.00 | MGLL (0.58) | MGLLTAAR1MPOSLC6A4HSPA5 | |
| SCHEMBL8618791 | 1.00 | MGLL (0.58) | MGLLTAAR1MPOSLC6A4HSPA5 | |
| SCHEMBL8055362 | 1.00 | MGLL (0.58) | MGLLTAAR1MPOSLC6A4HSPA5 | |
| SCHEMBL166339 | 0.98 | TAAR1 (0.56) | MGLLTAAR1MPOSLC6A4HSPA5 | |
| SCHEMBL169275 | 0.91 | TAAR1 (0.58) | MGLLTAAR1MPOSLC6A4HSPA5 | |
| SCHEMBL8401990 | 0.91 | MGLL (0.66) | MGLLTAAR1MPOSLC6A4HSPA5 | |
| SCHEMBL8402231 | 0.91 | MGLL (0.66) | MGLLTAAR1MPOSLC6A4HSPA5 | |
| SCHEMBL8398317 | 0.91 | MGLL (0.66) | MGLLTAAR1MPOSLC6A4HSPA5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110684031-A | Asymmetric synthesis method of trans-tetrahydropyranyl tetrahydroquinoline derived chiral compound | 西北大学 | 2020-01-14 | — | — | CN | claimed |
| EP-3542780-B1 | SERIES OF SKIN-WHITENING (LIGHTENING) COMPOUNDS | UNIGEN INC (US) | 2022-01-19 | — | — | EP | disclosed |
| CN-110684031-B | Asymmetric synthesis method of trans-tetrahydrofuran/pyranotetrahydroquinoline derived chiral compound | 西北大学 | 2021-07-02 | — | — | CN | disclosed |
| CN-110684031-B | Asymmetric synthesis method of trans-tetrahydrofuran/pyranotetrahydroquinoline derived chiral compound | 西北大学 | 2021-07-02 | — | — | CN | disclosed |
| CN-110684031-A | Asymmetric synthesis method of trans-tetrahydropyranyl tetrahydroquinoline derived chiral compound | 西北大学 | 2020-01-14 | — | — | CN | disclosed |
| CN-110684031-A | Asymmetric synthesis method of trans-tetrahydropyranyl tetrahydroquinoline derived chiral compound | 西北大学 | 2020-01-14 | — | — | CN | disclosed |
| EP-0622393-B1 | Modified aromatic polycarbonate resin and modified phenol for preparing it | TEIJIN CHEMICALS LTD (JP) | 1999-07-07 | — | — | EP | disclosed |
| US-5463013-A | Transparency, heat resistance, dimensional stability, tracking resistance | TEIJIN CHEMICALS, LTD. (JP) | 1995-10-31 | — | — | US | disclosed |
| EP-0622393-A2 | Modified aromatic polycarbonate resin and modified phenol for preparing it | Teijin Chemicals, Ltd. (JP) | 1994-11-02 | — | — | EP | disclosed |
| EP-0160258-B1 | (6,11-DIHYDRO-11-OXODIBENZ(BM,E)OXEPINYL)PENTANOLS, A PROCESS AND INTERMEDIATES FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS | HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) | 1989-09-27 | — | — | EP | disclosed |
| EP-0160258-A2 | (6,11-Dihydro-11-oxodibenz(bm,e)oxepinyl)pentanols, a process and intermediates for their preparation and their use as medicaments | HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) | 1985-11-06 | — | — | EP | disclosed |